Dolby Laboratories (DLB) Tops Q4 EPS by 10c, Offers Q1 & FY16 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Dolby Laboratories (DLB) Reports 4Q EPS Miss; B. Riley Cuts Price target to $41
October 22, 2015 9:31 AM EDTB. Riley maintained a Neutral rating on Dolby Laboratories (NYSE: DLB), and cut the price target to $41.00 (from $42.50), following the company's 4Q15 earnings results. Revenues of $229.5MM missed consensus of $235.8MM, and the low-end of the $230-240MM guidance. EPS came in at $0.27 compared to... More
